551 related articles for article (PubMed ID: 18189059)
1. Topical photodynamic therapy for dermatologic disorders: results and complications.
Redbord KP; Hanke CW
J Drugs Dermatol; 2007 Dec; 6(12):1197-202. PubMed ID: 18189059
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study.
Jeffes EW; McCullough JL; Weinstein GD; Fergin PE; Nelson JS; Shull TF; Simpson KR; Bukaty LM; Hoffman WL; Fong NL
Arch Dermatol; 1997 Jun; 133(6):727-32. PubMed ID: 9197826
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
[TBL] [Abstract][Full Text] [Related]
6. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
7. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going.
Gold MH; Goldman MP
Dermatol Surg; 2004 Aug; 30(8):1077-83; discussion 1083-4. PubMed ID: 15274696
[TBL] [Abstract][Full Text] [Related]
8. Short incubation PDT versus 5-FU in treating actinic keratoses.
Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with low-strength ALA, repeated applications and short contact periods (40-60 minutes) in acne, photoaging and vitiligo.
Serrano G; Lorente M; Reyes M; Millán F; Lloret A; Melendez J; Navarro M; Navarro M
J Drugs Dermatol; 2009 Jun; 8(6):562-8. PubMed ID: 19537381
[TBL] [Abstract][Full Text] [Related]
10. Severe cutaneous reaction to photodynamic therapy with blue light.
Moore MM; Reyna C; Hope RH
J Drugs Dermatol; 2011 Sep; 10(9):1057-8. PubMed ID: 22052277
[TBL] [Abstract][Full Text] [Related]
11. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
[TBL] [Abstract][Full Text] [Related]
12. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
Alexiades-Armenakas M
J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy.
Orringer JS; Sachs DL; Bailey E; Kang S; Hamilton T; Voorhees JJ
J Cosmet Dermatol; 2010 Mar; 9(1):28-34. PubMed ID: 20367670
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy update 2007.
Gold MH
J Drugs Dermatol; 2007 Nov; 6(11):1131-7. PubMed ID: 18038501
[TBL] [Abstract][Full Text] [Related]
15. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.
Touma D; Yaar M; Whitehead S; Konnikov N; Gilchrest BA
Arch Dermatol; 2004 Jan; 140(1):33-40. PubMed ID: 14732657
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
17. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
[TBL] [Abstract][Full Text] [Related]
18. Cellulitis as a postprocedural complication of topical 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis.
Wolfe CM; Hatfield K; Cognetta AB
J Drugs Dermatol; 2007 May; 6(5):544-8. PubMed ID: 17679192
[TBL] [Abstract][Full Text] [Related]
19. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage.
Gold MH; Bradshaw VL; Boring MM; Bridges TM; Biron JA
Dermatol Surg; 2006 Jun; 32(6):795-801; discussion 801-3. PubMed ID: 16792644
[TBL] [Abstract][Full Text] [Related]
20. Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid.
Maydan E; Nootheti PK; Goldman MP
J Drugs Dermatol; 2006 Sep; 5(8):804-6. PubMed ID: 16989196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]